Fairmount Partners August 2019: News

Fairmount is the most active M&A firm based in the Mid-Atlantic, with a national and international practice.  Since 2003, the firm has completed more than 215 transactions throughout North and South America, Europe, Asia and Australia.   Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context. 

  • Fairmount Partners represented GHO Capital in providing origination support and M&A advice as part of GHO’s portfolio company Quotient Sciences sale to global investment firm Permira. Based in London, GHO Capital is a leading European specialist healthcare investment advisor. The investment provides substantial new funding to fuel the next stage of Quotient’s growth.
  • Fairmount assisted longtime client ICON (Nasdaq: ICLR) as it continues to expand its investigative site business by purchasing a majority stake in MeDiNova Research, which operates a network of 33 sites in key markets in the UK, Europe, and Africa. Coventry, England-based MeDiNova Research is one of the largest site groups in Europe and will help ICON boost its geographic footprint and its patient recruitment capabilities while complementing its existing site network in the U.S., known as PMG Research, which it bought back in 2015. This is Fairmount’s 15th transaction with ICON.
  • Fairmount assisted Novasyte, the tech-enabled outsourcing experts for medical device and diagnostic manufacturers, as exclusive financial advisor to the company in a recently completed transaction. Founded in 2008 and based in Carlsbad, California, Novasyte offers innovative sales, clinical support, and field services for the medical device and diagnostic industries. The counter party has elected to not announce the transaction, or any details of the transaction, and as a courtesy we are not including their identity. Please go to www.novasyte.com for more information. 
  • Fairmount Partners represented Regulatory & Clinical Research Institute, Inc. (RCRI), in their sale to Covance, the drug development business of LabCorp® (NYSE: LH). RCRI is the leading clinical research organization, medical device consulting firm and strategic regulatory expert based in Minneapolis. RCRI has built a reputation for designing and implementing the most complex medical device trials, applying an integrated, regulatory-centric approach at every stage of medical device development. LabCorp®, an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. 
  • Fairmount Partners advised Goodwin Biotechnology, Inc. in securing the Company’s first outside financing with growth capital to help fund its next stage of expansion including quadrupling capacity – particularly for commercial manufacturing. Goodwin is a full GMP, FDA-registered biopharmaceuticals CDMO that offers a fully integrated Single Source Solution™ from Cell Line Development, Process Development including Bioconjugation, Scale-Up, cGMP Contract Manufacturing and Aseptic Fill/Finish of mammalian cell-culture derived life-saving monoclonal antibodies, recombinant proteins, vaccines, and Antibody Drug Conjugates (ADCs). The investment was made by Signet Healthcare Partners, a New York based growth equity firm specializing in healthcare investments. This is our second transaction with the team at Signet.
  • Fairmount Partners represented Versify Solutions in their acquisition by MCG Energy Solutions. MCG’s rapidly expanding role in the North American energy software industry is furthered by the Versify acquisition, which is MCG’s fourth major acquisition since 2017.  Versify Solutions provides a suite of web-based software-as-a-service (SaaS) applications for Energy, Utility and Industrial companies. Versify’s products alleviate the stress and pressure of operational and commercial performance and transition it into operational and commercial excellence! We help eliminate the frustration and difficulty associated with managing complex business processes and operations across a multitude of assets, regions and stakeholders.
  • Fairmount Partners represented Duck Donuts Franchising Company, the franchisor operation supporting the Company’s Duck Donuts franchised locations, in closing on a credit facility with Centric Bank.  Duck Donuts®, one of the nation’s fastest-growing donut franchises in the U.S., known for serving Warm, Delicious and Made-to-Order! ® donuts, was founded in Duck, North Carolina by Russ DiGilio in 2006. Centric Bank (www.centricbank.com) is headquartered in south central Pennsylvania and remains the leader in organic loan growth in central Pennsylvania.  A locally-owned, locally-loaned community bank, Centric provides highly competitive and pro-growth core financial services to businesses, professionals, individuals and families.

©2018 PACT All Rights Reserved